Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Tête et cou
- | Specialty :
- Thérapies Ciblées
Extract
A randomized, open-label phase II study of BIBW 2992 versus cetuximab (erbitux) in patients with metastatic or recurrent head and neck squamous cell carcinoma (HNSCC) after failure of platinum-containing therapy with a cross-over period for progressing patients
Scientific Abstract
en cours d'intégration;